HXL

Hexima Limited

About HXL

Hexima Limited (HXL) is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human therapeutics. Hexima is developing pezadeftide as a potentially safe, convenient and effective topical prescription treatment for fungal nail infections (onychomycosis).

Buy Australian shares starting with HXL. Invest today with a CHESS-sponsored broker!

Sector

Health Care

CEO

Industry

Biotechnology

Website

hexima.com.au

Market Capitalisation

$3M

Price-earnings ratio

-0.23

Dividend yield

0.00%

High today

$0.02

Low today

$0.02

Open price

$0.02

52-week high

$0.42

52-week low

$0.01

Announcements

HXL FAQs

How much is one share of Hexima Limited?

One share of Hexima Limited is valued at $0.02.

What is the ticker symbol for Hexima Limited?

The ticker symbol for Hexima Limited is HXL.

How do I buy HXL shares in Australia?

To buy HXL stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in HXL

What is the 52-week high for Hexima Limited stock?

The Hexima Limited 52-week high stock price is $0.42.

What is the 52-week low for Hexima Limited stock?

The Hexima Limited 52-week low stock price is $0.01.

What is the market capitalisation of Hexima Limited HXL?

As of 26/03/2023 Hexima Limited has a market cap of $3M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.